Cyberonics Investor

Cyberonics, Inc., (NASDAQ: CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy system, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy system uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy system in selected markets worldwide. Cyberonics is committed to advancing device-based solutions that improve the lives of patients and their families. Their core beliefs guide us to design, develop and market patient-focused medical device solutions for people affected by epilepsy, depression, and other chronic disorders.
Technology: N/A
Industry: Precision Medicine
Headquarters: Houston, Texas, United States
Founded Date: 1987
Employees Number: 501-1000
Funding Status: M&A
Investor Type: undisclosed
Investment Stage: Undisclosed
Number Of Exits: 1

Visit Website
Register and Claim Ownership